Knockdown of GIPC2 in LS180 and HT-29 cells via siRNA significantly inhibited cell proliferation over a four-day period (Figures 7C–E), confirming GIPC2’s role as an oncogenic driver in CRC. Here, GIPC2 is linked to colorectal carcinoma.